BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1880444)

  • 1. [Effects of cefixime and cefaclor on pharyngeal flora in children].
    Sakata H; Maruyama S
    Kansenshogaku Zasshi; 1991 May; 65(5):546-51. PubMed ID: 1880444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
    Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
    Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of cefaclor and cefixime on nasopharyngeal pathogens in children].
    Tomiyama M
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Apr; 98(4):659-68. PubMed ID: 7782974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children.
    Harrison CJ; Chartrand SA; Pichichero ME
    Pediatr Infect Dis J; 1993 Jan; 12(1):62-9. PubMed ID: 8417428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefixime vs. cefaclor in the treatment of acute otitis media in children: a randomized, comparative study.
    Rodriguez WJ; Khan W; Sait T; Chhabra OP; Bell TA; Akram S; Kohlbrenner VM
    Pediatr Infect Dis J; 1993 Jan; 12(1):70-4. PubMed ID: 8417429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
    Reed BD; Huck W; Zazove P
    J Fam Pract; 1991 Feb; 32(2):138-44. PubMed ID: 1990041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies on cefixime in the pediatric field].
    Nakashima S; Hayakawa F; Nakashima T; Miyachi Y; Hakamada S; Kuno K
    Jpn J Antibiot; 1986 Apr; 39(4):1076-86. PubMed ID: 3761538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients.
    Risser WL; Barone JS; Clark PA; Simpkins DL
    Pediatr Infect Dis J; 1987 Oct; 6(10):1002-6. PubMed ID: 3320921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
    Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
    Finegold SM; Ingram-Drake L; Gee R; Reinhardt J; Edelstein MA; MacDonald K; Wexler H
    Antimicrob Agents Chemother; 1987 Mar; 31(3):443-6. PubMed ID: 3579262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
    Stutman HR; Arguedas AG
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S204-8; discussion S209-11. PubMed ID: 1617039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.
    Kenna MA; Bluestone CD; Fall P; Stephenson J; Kurs-Lasky M; Wucher FP; Blatter MM; Reisinger KS
    Pediatr Infect Dis J; 1987 Oct; 6(10):992-6. PubMed ID: 3696840
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of cefixime in the treatment of otitis media in infants and children.
    Bluestone CD
    Pediatr Infect Dis J; 1993 Jan; 12(1):75-82. PubMed ID: 8417430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
    Neu HC
    Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic antibiotics for treatment of the conjunctivitis-otitis media syndrome.
    Bodor FF
    Pediatr Infect Dis J; 1989 May; 8(5):287-90. PubMed ID: 2631693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of cefixime in comparison with penicillin V in bacterial pharyngitis and tonsillitis in children. Cefixime Study Group].
    Adam D; Hostalek U
    Klin Padiatr; 1994; 206(1):26-9. PubMed ID: 8152203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
    Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
    Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies on cefixime in pediatrics].
    Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.